Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Omega-7 fatty acids, particularly palmitoleic acid, have garnered interest for their potential role in supporting healthy triglyceride levels. Scientific evidence suggests that palmitoleic acid, a monounsaturated fatty acid found in macadamia nuts and sea buckthorn oil, may help lower triglycerides and improve lipid profiles. Several small clinical trials and animal studies indicate that supplementation with omega-7 can reduce serum triglyceride levels, likely by enhancing insulin sensitivity and modulating hepatic lipid metabolism. For example, a randomized, double-blind, placebo-controlled trial published in the journal Lipids in Health and Disease (2014) found that supplementation with purified palmitoleic acid significantly reduced triglyceride levels in adults with borderline high triglycerides over 30 days. Other studies have noted improvements in markers of metabolic syndrome, including reductions in C-reactive protein and improvements in HDL cholesterol.

However, while the early data is promising, the body of evidence is still relatively limited in both size and duration. Most studies have small sample sizes and short intervention periods. In addition, not all studies have found significant effects, and there is still debate about the optimal dose and long-term safety of omega-7 supplementation. Major medical guidelines do not currently recommend omega-7 for hypertriglyceridemia, pending larger and longer-term clinical trials. Thus, while there is some scientific validation, the evidence is considered moderate (rated 3/5), and omega-7 should not be used as a first-line therapy for high triglycerides.

More about omega-7 fatty acids
More about Triglycerides (high)

Other ingredients used for Triglycerides (high)

Other health conditions supported by omega-7 fatty acids

Products containing omega-7 fatty acids